Tag Archives: marketing application

Stem Cells: Which Way to the Clinic? (Updated!)

For over two decades, the potential of stem cell therapy to cure some of our most devastating diseases has been touted by the media.  A Google search of “stem cell research” yields over 57 million results, and yet, in mid-2012, … Continue reading

Posted in FDA, Industry News | Tagged , , , , , , , , , , | 3 Comments

New FDA Guidances from April 2012

Here’s a list of the notable guidances released by FDA in April 2012. Continue reading

Posted in FDA, Regulatory Strategy | Tagged , , , , , , | Comments Off on New FDA Guidances from April 2012

FDA Reorganizes Oncology and Hematology Divisions

When we are no longer able to change a situation, we are challenged to change ourselves. Victor Frankl The FDA recently announced that it is reorganizing three divisions (Hematology Products, Drug Oncology Products, and Biologic Oncology Products) from the Office … Continue reading

Posted in Clinical Trials, FDA, Industry News, Regulatory Strategy | Tagged , , , , , , | Comments Off on FDA Reorganizes Oncology and Hematology Divisions

Recap of the DIA Annual Meeting 2011

The 47th Annual DIA Meeting was held on 19-23 June 2011 in Chicago and was a great success with thousands of attendees from the health care industry and regulators from around the world including representatives from the FDA, the EMA, … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Recap of the DIA Annual Meeting 2011

Clinical Trials in South Africa 101

South Africa has a mixture of both first and third world diseases and a large number of experienced research sites, making the country an excellent location for clinical trials in many indications. As we are a southern hemisphere country, recruitment … Continue reading

Posted in Clinical Trials | Tagged , , , , , , , , , , , | 1 Comment